Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 04-1993 | 01-1993 | 10-1992 | 07-1992 | 04-1992 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,126 | 2,793 | 2,808 | 3,013 | 2,781 |
| TOTAL | $3,126 | $2,793 | $2,808 | $3,013 | $2,781 |
| Non-Current Assets | |||||
| PPE Net | 8,629 | 8,598 | 8,664 | 8,303 | 7,819 |
| Other Non-Current Assets | 4,429 | 4,472 | 4,459 | 4,616 | 4,670 |
| TOTAL | $13,058 | $13,070 | $13,123 | $12,919 | $12,489 |
| Total Assets | $16,184 | $15,863 | $15,931 | $15,932 | $15,270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,248 | 3,944 | 3,570 | 2,876 | 3,493 |
| Accrued Expenses | 3,166 | 2,776 | 3,074 | 2,936 | 2,671 |
| TOTAL | $11,607 | $8,830 | $7,617 | $7,161 | $7,448 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 831 | 821 | 812 | 797 | 782 |
| TOTAL | $2,481 | $2,534 | $2,542 | $2,541 | $2,536 |
| Total Liabilities | $14,088 | $11,364 | $10,159 | $9,702 | $9,984 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -7,200 | -171 | -132 | 108 | 488 |
| TOTAL | $16,508 | $16,507 | $16,546 | $16,786 | $19,166 |
| Total Liabilities And Equity | $30,596 | $27,871 | $26,705 | $26,488 | $29,150 |